CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc.:
Launched EVOMELA® (melphalan for injection, multiple myeloma) in August '19, only melphalan commercially available in China: $4.2 m Q3 20 revenues/guiding FY 2020 $14 m revenue. Partnership w BioInvent: acq'd Greater China comm/dev rights to anti-FcyRIIB mAb w potential applications across multiple tumor types in 1L & refractory settings. Co-commercial asset CNCT-19/CD19 CAR-T (partnered w/ Juventas): ongoing Ph 1 trials in B-NHL and B-ALL, exp to initiate registration trials by YE 2020. Exp to initiate Ph 1 study for CID-103 (anti-CD38 mAb) in EU in Q1 2021. Strategic BD approach enables opportunistic pipeline expansion.
Sector/Industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Asia, US - South Atlantic
Disease Space
Oncology
Listing
Public, USA
Market Cap
100MM - 500MM
Website:
Profiles:
Address:
9620 Medical Center Drive
Suite 300
Rockville, MD 20850
United States
Suite 300
Rockville, MD 20850
United States
More info:
My account:
Company Participants at Solebury Trout Corporate Access 1x1 Calls - Week of April 13
- Wei-Wu He, PhD, CEO & Chairman
Top 10 Holders of CASI Pharmaceuticals Inc
| Institution | OS (%) | Position | Mkt Val ($MM) | Source | Filing Date |
|---|---|---|---|---|---|
| IDG-Accel China Growth Fund III Associates LP | 8.28 | 7,973,536 | 23.12 | 13F | 9/30/20 |
| Federated Global Investment Management Corp. | 7.16 | 6,900,000 | 20.01 | 13F | 9/30/20 |
| Consonance Capital Management LP | 6.81 | 6,560,000 | 19.02 | 13F | 9/30/20 |
| The Vanguard Group, Inc. | 3.06 | 2,947,155 | 8.55 | Funds | 11/30/20 |
| Vanguard Group, Inc. (Subfiler) | 2.88 | 2,775,646 | 8.05 | 13F | 9/30/20 |
| BlackRock Fund Advisors | 1.85 | 1,786,196 | 5.18 | 13F | 9/30/20 |
| Ikarian Capital LLC | 1.60 | 1,539,910 | 4.47 | 13F | 9/30/20 |
| Wellington Shields & Co. LLC | 1.54 | 1,479,623 | 4.29 | 13F | 9/30/20 |
| Wellington Shields Capital Management LLC | 1.48 | 1,424,731 | 4.13 | 13F | 9/30/20 |
| BlackRock Institutional Trust Co. NA | 1.40 | 1,344,280 | 3.90 | 13F | 9/30/20 |
Ownership data is sourced through FactSet.
Stock Market Data
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia.
Data delayed 15 minutes unless otherwise indicated (view
delay times for all
exchanges). RT=Real-Time, RTB=Real-Time
BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time
NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of
Day, PD=Previous Day. Market Data powered by
QuoteMedia.
Terms of Use.